Concert Pharma (CNCE) Tops Q2 EPS by 3c

August 9, 2016 8:15 AM EDT
Get Alerts CNCE Hot Sheet
Trade CNCE Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Concert Pharma (NASDAQ: CNCE) reported Q2 EPS of ($0.60), $0.03 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $71 thousand versus the consensus estimate of $30 thousand.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment